End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0017 USD | +13.33% | +70.00% | -99.73% |
04-25 | Labcorp beats quarterly estimates on strong testing demand | RE |
04-25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-99.73% | 487K | |
-17.41% | 11.29B | |
+64.21% | 3.91B | |
-30.17% | 2.29B | |
-11.81% | 2.23B | |
-24.97% | 1.61B | |
+35.08% | 1.19B | |
-3.28% | 752M | |
-27.04% | 458M | |
+13.72% | 338M |
- Stock Market
- Equities
- NVTA.Q Stock
- News Invitae Corporation
- Invitae : Oppenheimer Adjusts Price Target for Invitae to $51 From $48, Maintains Outperform Rating